Browsing Tag
VRE
2 posts
LABT lists on Nasdaq: Can Lakewood-Amedex Biotherapeutics’ Bisphosphocin class crack antibiotic resistance?
Lakewood-Amedex Biotherapeutics (LABT) lists on Nasdaq with Nu-3 antimicrobial targeting infected diabetic foot ulcers. Read what it means for AMR investors.
Nano-Mupirocin breakthrough: Revium Rx targets MRSA and VRE with next-generation antibiotic innovation
Find out how Revium Rx’s Nano-Mupirocin could redefine antibiotic therapy against MRSA and VRE and reshape the global antimicrobial resistance market.